As observed by flow cytometry, the amount of CD4+ cells increased significantly as well as CD3+ (Figures 3D,E) and Nkp46+ cells with Pirfenidone treatment within the tumor tissues, whereas CD19+ cells were unaffected by the treatment. This evidence concerns the gene CD19 and neoplasm.